Table 17.
Source of funding |
No conclusion on reported outcome |
Positive |
Negative |
Pearson’s chi Square | Fisher’s exact p value | |
---|---|---|---|---|---|---|
n (%) $$ | n (%) $$ | n (%) $$ | ||||
NEC N = 12 |
Industry |
3 (25) |
|
1 (8.3) |
0.511 |
0.782 |
|
None/Not clear |
2 (16.7) |
1 (8.3) |
1 (8.3) |
|
|
|
Non industry |
2 (16.7) |
2 (16.7) |
0 |
|
|
|
|
7 (58.3) |
3 (25) |
2 (16.7) |
|
|
Sepsis N = 10 |
Industry |
2 (20) |
|
|
0.274 |
0.500 |
|
None/Not clear |
2 (20) |
|
1 (10) |
|
|
|
Non industry |
5 (50) |
|
|
|
|
Antibiotic use N = 16 |
Industry |
4 (25) |
3 (18.8) |
|
0.093 |
0.141 |
|
None/Not clear |
4 (25) |
|
|
|
|
Non industry | 5 (31.3) |
$$ Overall percentage.